Skip to main content

About Study Course

Credit points / ECTS:1.33 / 2
Course supervisor:Larisa Umnova
Study type:Full time
Course level:Master's
Target audience:Clinical Pharmacy
Language:Latvian
Study course descriptionFull description, Full time
Branch of science:Basic Sciences of Medicine, including Pharmacy; Clinical Pharmacy

Objective

To provide students with knowledge in clinical areas – pathophysiology of diseases, clinical manifestations of nephrological diseases, evaluation of examinations, basic methods of treatment and pharmacotherapy options for renal and urinary tract diseases.
The study module comprises an integrated learning cycle in which the student is gradually introduced to the pathological physiology of a group of diseases, clinical pharmacology, clinical manifestations, examination possibilities, interpretation of examination data, principles and types of treatment and pharmacotherapy possibilities.

Prerequisites

Basic human anatomy, basic physiology and pathologies, medical biochemistry, pharmacology.

Learning outcomes

Knowledge

As a result of successfully completing the course, the student will have knowledge of the following:
• causes and mechanisms of kidney and urinary tract diseases;
• the most common clinical manifestations and complications of kidney and urinary tract diseases;
• options for kidney and urinary tract examination and interpretation of results;
• basic types of treatment of kidney and urinary tract diseases;
• pharmacotherapy options for kidney and urinary tract diseases.

Skills

The student will be able:
• to analyse and interpret the results of kidney and urinary tract examinations;
• to evaluate pharmacotherapy of nephrological patients.

Competence

The student will be able:
• in collaboration with the medical practitioners, to determine a pharmacotherapy plan for an individual patient with a kidney and urinary tract disease;
• to assess the advantages and disadvantages of pharmacotherapy methods in relation to the patient’s examination data;
• to monitor the progress of pharmacotherapy, predict side effects and plan the prevention thereof, and provide the necessary information to other medical specialists.

Study course planning

Planning period:Year 2024, Autumn semester
Study programmeStudy semesterProgram levelStudy course categoryLecturersSchedule
Clinical Pharmacy, FFMp1Master’sRequired
Planning period:Year 2025, Spring semester
Study programmeStudy semesterProgram levelStudy course categoryLecturersSchedule
Clinical Pharmacy, FFMpz1Master’sRequired